The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
Distalmotion’s Dexter surgical robotics system challenges the clinical and economic barriers that limit ambulatory surgical ...
GlobalData on MSN
Distalmotion seeks FDA clearance for DEXTER use
The FDA has authorised the company to begin a US myomectomy trial through an investigational device exemption.
Distalmotion announced today that it submitted a 510(k) application to the FDA to expand indications for its Dexter surgical ...
Lausanne, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in outpatient sites of care, today announced the ...
Lausanne, Switzerland, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic ...
JACKSONVILLE, Fla., Sept. 4, 2025 /PRNewswire/ -- Distalmotion and First Citizens Bank's Healthcare Equipment Finance group today announced a new financing program designed to provide hospitals, ...
Distalmotion also received FDA approval for a US myomectomy trial via Investigational Device Exemption (IDE) to further ...
Lausanne, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in outpatient sites of care, today announced that ...
As more procedures migrate from hospitals to outpatient settings, robotic surgery is following suit — but not all technologies are designed with ASCs in mind. At Becker’s 31st Annual Meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results